AR108777A1 - Compuestos antibacterianos - Google Patents
Compuestos antibacterianosInfo
- Publication number
- AR108777A1 AR108777A1 ARP170101554A ARP170101554A AR108777A1 AR 108777 A1 AR108777 A1 AR 108777A1 AR P170101554 A ARP170101554 A AR P170101554A AR P170101554 A ARP170101554 A AR P170101554A AR 108777 A1 AR108777 A1 AR 108777A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkylenyl
- alkyl
- optionally substituted
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Reivindicación 1: Un compuesto de fórmula (1): A-L¹-Y-L²-R-B (1) en la que A es un grupo cíclico que tiene la fórmula (2), en la que G³ es CH o N cuando la línea discontinua representa un doble enlace, o CH₂, NH u O cuando la línea discontinua representa un enlace sencillo; C¹ representa los átomos necesarios para formar un ciclo alifático o aromático de seis miembros que comprende opcionalmente uno o más heteroátomos seleccionados de átomo de nitrógeno y átomo de oxígeno, estando dicho ciclo opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo que consiste en átomo de halógeno, grupo alquilo C₁₋₃, grupo ciano, grupo oxo (=O), y grupo alcoxi C₁₋₃; L¹ es un enlace s, o grupo alquilenilo C₁₋₃, opcionalmente sustituido con grupo hidroxi; Y es un anillo seleccionado del grupo que consiste en un anillo de piperidinilo, piperazinilo, pirrolidinilo, 1-3 ciclobutilo, 1-3 ciclopentilo, 1-2 ciclopropilo, azetidinilo, azabiciclo-octilo, morfolinilo y ciclohexilo, estando dicho anillo opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo que consiste en grupo hidroxi, grupo alquilenil C₁₋₃-OH, grupo alquilenil C₁₋₃-O-alquilo C₁₋₃, grupo alquilenil C₁₋₃-CONRR, y grupo CONRR, en los que R y R son átomo de hidrógeno o alquilo C₁₋₃; L² es un enlace s, grupo -alquilenilo C₁₋₃-, grupo NR, grupo NR-alquilenilo C₁₋₃, grupo alquilenil C₁₋₃-NR, grupo NR-alquilenil C₁₋₃-NR, o grupo alquilenil C₁₋₃-NR-alquilenilo C₁₋₃, estando dicho grupo opcionalmente sustituido con un grupo hidroxi, en los que R es hidrógeno, alquilo C₁₋₃, alquilenil C₁₋₃-OH, alquilenil C₁₋₃-O-alquilo C₁₋₃, o alquilenil C₁₋₃-CONRR, en el que R y R son un átomo de hidrógeno o alquilo C₁₋₃; R es un enlace s o un anillo heterocíclico, alifático o aromático, que tiene 5 miembros, que contiene uno o más átomo de nitrógeno, opcionalmente sustituido con CH₂OH, CH₂CN, CN o CONRR, en el que R y R son un átomo de hidrógeno o alquilo C₁₋₃; y B es un grupo cíclico que tiene la fórmula (3), en la que G⁶ es CH o N; R² es un átomo de hidrógeno o un átomo de halógeno; y sales de adición con ácidos o bases orgánicos o inorgánicos farmacéuticamente aceptables, enantiómeros, N-óxidos y sales de amonio cuaternario de dicho compuesto de fórmula (1).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16173550 | 2016-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR108777A1 true AR108777A1 (es) | 2018-09-26 |
Family
ID=56116327
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101555A AR108778A1 (es) | 2016-06-08 | 2017-06-07 | Compuestos antibacterianos |
| ARP170101554A AR108777A1 (es) | 2016-06-08 | 2017-06-07 | Compuestos antibacterianos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101555A AR108778A1 (es) | 2016-06-08 | 2017-06-07 | Compuestos antibacterianos |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US10633366B2 (es) |
| EP (2) | EP3468970A1 (es) |
| JP (2) | JP2019517545A (es) |
| KR (2) | KR20190019083A (es) |
| CN (2) | CN109790157A (es) |
| AR (2) | AR108778A1 (es) |
| AU (2) | AU2017276627A1 (es) |
| BR (2) | BR112018075297A2 (es) |
| CA (2) | CA3025270A1 (es) |
| CY (1) | CY1123194T1 (es) |
| DK (1) | DK3468975T3 (es) |
| EA (2) | EA201892822A1 (es) |
| ES (1) | ES2802233T3 (es) |
| HR (1) | HRP20200894T1 (es) |
| HU (1) | HUE049547T2 (es) |
| IL (2) | IL263285A (es) |
| LT (1) | LT3468975T (es) |
| MA (1) | MA45221A (es) |
| MD (1) | MD3468975T2 (es) |
| ME (1) | ME03738B (es) |
| MX (2) | MX2018015126A (es) |
| PL (1) | PL3468975T3 (es) |
| PT (1) | PT3468975T (es) |
| RS (1) | RS60511B1 (es) |
| SG (2) | SG11201810352XA (es) |
| SI (1) | SI3468975T1 (es) |
| WO (2) | WO2017211760A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017211760A1 (en) * | 2016-06-08 | 2017-12-14 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | New antibacterial compounds |
| WO2022109360A1 (en) | 2020-11-23 | 2022-05-27 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| US11970502B2 (en) | 2021-05-04 | 2024-04-30 | Enanta Pharmaceuticals, Inc. | Macrocyclic antiviral agents |
| CN113698412A (zh) * | 2021-09-01 | 2021-11-26 | 临沂大学 | 一种香豆素并[4,3-b]吡咯类衍生物及其合成方法和应用 |
| US11858945B2 (en) | 2021-11-12 | 2024-01-02 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| US11912714B2 (en) | 2021-11-12 | 2024-02-27 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2023086400A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| US11993600B2 (en) | 2021-12-08 | 2024-05-28 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| US12006291B2 (en) | 2022-01-11 | 2024-06-11 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid |
| CN115850672B (zh) * | 2022-11-25 | 2024-07-19 | 浙江甬仑聚嘉新材料有限公司 | 一种液晶聚合物及其制备方法和应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2886570B2 (ja) * | 1989-09-29 | 1999-04-26 | エーザイ株式会社 | 縮合ヘテロ環を有する化合物 |
| MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| US5607936A (en) | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| FR2822154B1 (fr) | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| JP2005532368A (ja) * | 2002-06-12 | 2005-10-27 | アボット・ラボラトリーズ | メラニン濃縮ホルモン受容体の拮抗薬 |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| JP5314244B2 (ja) * | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
| AU2006230364B2 (en) | 2005-03-31 | 2012-09-13 | Janssen Pharmaceutica N.V. | Bicyclic pyrazole compounds as antibacterial agents |
| US20090131444A1 (en) * | 2005-05-24 | 2009-05-21 | Astrazeneca Ab | Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity |
| MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| WO2006137485A1 (ja) * | 2005-06-24 | 2006-12-28 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
| CN101346379A (zh) * | 2005-10-21 | 2009-01-14 | 葛兰素集团有限公司 | 用作抗菌剂的周环并合的三环化合物 |
| CN101679357A (zh) * | 2007-05-09 | 2010-03-24 | 辉瑞大药厂 | 取代的杂环衍生物及其组合物和作为抗菌剂的药物用途 |
| JP5620636B2 (ja) * | 2007-11-26 | 2014-11-05 | 富山化学工業株式会社 | 新規な複素環化合物またはその塩を含有する抗菌剤 |
| US20110071155A1 (en) * | 2008-05-23 | 2011-03-24 | Carlos Alemparte-Gallardo | Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials |
| CA2725726A1 (en) | 2008-05-23 | 2009-11-26 | Glaxo Group Limited | Tricyclic nitrogen containing compounds and their use as antibacterials |
| TW201022279A (en) * | 2008-11-14 | 2010-06-16 | Astrazeneca Ab | Chemical compounds |
| US8318940B2 (en) | 2009-01-15 | 2012-11-27 | Glaxo Group Limited | Naphthyridin-2 (1 H)-one compounds useful as antibacterials |
| CA2750047A1 (en) | 2009-01-21 | 2010-07-29 | Basilea Pharmaceutica Ag | Novel bicyclic antibiotics |
| US9156822B2 (en) | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
| WO2012117421A1 (en) * | 2011-03-02 | 2012-09-07 | Orchid Research Laboratories Ltd | Histone deacetylase inhibitors |
| AU2012275499A1 (en) * | 2011-06-27 | 2013-12-19 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
| CA2854264A1 (en) | 2011-11-08 | 2013-05-16 | Actelion Pharmaceuticals Ltd | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives |
| EP2785721A1 (en) | 2011-11-30 | 2014-10-08 | Actelion Pharmaceuticals Ltd. | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| CN105218501A (zh) * | 2014-07-03 | 2016-01-06 | 南京大学 | 含哌嗪环的香豆素类衍生物及其制备与在抗菌药物中的应用 |
| PE20170501A1 (es) * | 2014-08-22 | 2017-04-27 | Glaxosmithkline Ip Dev Ltd | Un procedimiento que comprende compuestos que administran a un sujeto infectado con neisseria gonorrhoeae |
| MA41168A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| WO2017211760A1 (en) * | 2016-06-08 | 2017-12-14 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | New antibacterial compounds |
-
2017
- 2017-06-05 WO PCT/EP2017/063601 patent/WO2017211760A1/en unknown
- 2017-06-05 EP EP17727595.5A patent/EP3468970A1/en not_active Withdrawn
- 2017-06-05 KR KR1020187036945A patent/KR20190019083A/ko not_active Application Discontinuation
- 2017-06-05 AU AU2017276627A patent/AU2017276627A1/en not_active Abandoned
- 2017-06-05 HU HUE17732775A patent/HUE049547T2/hu unknown
- 2017-06-05 MD MDE20190471T patent/MD3468975T2/ro not_active IP Right Cessation
- 2017-06-05 SG SG11201810352XA patent/SG11201810352XA/en unknown
- 2017-06-05 MX MX2018015126A patent/MX2018015126A/es unknown
- 2017-06-05 ES ES17732775T patent/ES2802233T3/es active Active
- 2017-06-05 SG SG11201810389XA patent/SG11201810389XA/en unknown
- 2017-06-05 AU AU2017276626A patent/AU2017276626A1/en not_active Abandoned
- 2017-06-05 US US16/307,410 patent/US10633366B2/en not_active Expired - Fee Related
- 2017-06-05 BR BR112018075297-5A patent/BR112018075297A2/pt not_active IP Right Cessation
- 2017-06-05 CA CA3025270A patent/CA3025270A1/en not_active Abandoned
- 2017-06-05 CA CA3025624A patent/CA3025624A1/en not_active Abandoned
- 2017-06-05 BR BR112018075334-3A patent/BR112018075334A2/pt not_active IP Right Cessation
- 2017-06-05 JP JP2018564236A patent/JP2019517545A/ja active Pending
- 2017-06-05 EP EP17732775.6A patent/EP3468975B1/en active Active
- 2017-06-05 MX MX2018015125A patent/MX2018015125A/es unknown
- 2017-06-05 RS RS20200735A patent/RS60511B1/sr unknown
- 2017-06-05 KR KR1020187036946A patent/KR20190019084A/ko not_active Application Discontinuation
- 2017-06-05 CN CN201780042649.1A patent/CN109790157A/zh active Pending
- 2017-06-05 PT PT177327756T patent/PT3468975T/pt unknown
- 2017-06-05 US US16/307,193 patent/US10640488B2/en not_active Expired - Fee Related
- 2017-06-05 DK DK17732775.6T patent/DK3468975T3/da active
- 2017-06-05 MA MA045221A patent/MA45221A/fr unknown
- 2017-06-05 CN CN201780039687.1A patent/CN109415373A/zh active Pending
- 2017-06-05 SI SI201730306T patent/SI3468975T1/sl unknown
- 2017-06-05 EA EA201892822A patent/EA201892822A1/ru unknown
- 2017-06-05 ME MEP-2020-112A patent/ME03738B/me unknown
- 2017-06-05 LT LTEP17732775.6T patent/LT3468975T/lt unknown
- 2017-06-05 PL PL17732775T patent/PL3468975T3/pl unknown
- 2017-06-05 WO PCT/EP2017/063600 patent/WO2017211759A1/en unknown
- 2017-06-05 JP JP2018564240A patent/JP2019517546A/ja active Pending
- 2017-06-05 EA EA201892815A patent/EA201892815A1/ru unknown
- 2017-06-07 AR ARP170101555A patent/AR108778A1/es unknown
- 2017-06-07 AR ARP170101554A patent/AR108777A1/es unknown
-
2018
- 2018-11-26 IL IL263285A patent/IL263285A/en unknown
- 2018-11-26 IL IL263283A patent/IL263283A/en unknown
-
2020
- 2020-06-04 HR HRP20200894TT patent/HRP20200894T1/hr unknown
- 2020-06-29 CY CY20201100597T patent/CY1123194T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR108777A1 (es) | Compuestos antibacterianos | |
| AR100645A1 (es) | Derivados de pirazolo-pirimidina | |
| AR106763A1 (es) | Oxadiazoles sustituidos para combatir hongos fitopatógenos | |
| AR106605A1 (es) | Oxadiazoles sustituidos para combatir hongos fitopatógenos | |
| AR117916A1 (es) | Compuesto heterocíclico y su uso | |
| AR099995A1 (es) | Piridilamidinas fungicidas | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| NI201500130A (es) | 2-azabiciclo sustituidos y su uso como moduladores del receptor de orexina | |
| AR112348A1 (es) | Compuestos bicíclicos de pirazolo y triazolo como inhibidores de quinasas jak | |
| ES2684517T3 (es) | Compuestos de heterociclilo como inhibidores de MEK | |
| AR110789A1 (es) | Compuestos moduladores del receptor de hidrocarburos de arilo (ahr) | |
| AR091193A1 (es) | HETEROCICLOS DE 5 MIEMBROS QUE CONTIENEN NITROGENO SUSTITUIDO POR CARBOXAMIDA O SULFONAMIDA COMO MODULADORES PARA EL RECEPTOR NUCLEAR HUERFANO RORg | |
| AR110790A1 (es) | Compuestos moduladores del receptor de hidrocarburos de arilo (ahr) | |
| AR113842A1 (es) | Derivados de tiazol microbiocidas | |
| AR105929A1 (es) | Derivados de 2-difluorometil-nicotin(tio)carboxanilida sustituidos y su uso como fungicidas | |
| AR111682A1 (es) | Derivados de imidazopirimidina con sustituyentes fenilo y piridilo que contienen azufre | |
| AR102544A1 (es) | Compuestos derivados de dihidrohidantoína como herbicidas | |
| AR103414A1 (es) | Derivados de hidroxialquil-piperazina como moduladores del receptor cxcr3 | |
| AR097252A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida | |
| AR114430A1 (es) | Compuestos herbicidas | |
| AR097253A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida | |
| AR088596A1 (es) | Compuestos de bencilamina sustituidos | |
| AR101222A1 (es) | Derivados de piridona | |
| AR110432A1 (es) | Amidas aromáticas de ácidos carboxílicos | |
| AR115020A1 (es) | Compuesto heterocíclico nitrogenado y su uso como antagonista del receptor nmda |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |